Table I.
Baseline characteristics of treatment groups including means ± standard deviations and/or medians with 1st and 3rd quartiles. PNS: Peroneal nerve stimulation; UC: usual care; DF: dorsiflexion; mEFAP: Modified Emory Functional Ambulation Profile; SSQOL: Stroke Specific Quality of Life; T1: first outcome assessment (baseline).
| PNS n= 54 (mean ± SD) |
Median (1st quartile, 3rd quartile) |
UC n = 56 (mean ± SD) |
Median (1st quartile, 3rd quartile) |
p-value | |
|---|---|---|---|---|---|
| Age (yrs) | 52.8 ± 12.2 | 52.5 (44, 60) | 53.2 ± 10.1 | 54 (46.5, 59.5) | 0.84 |
| Male: female | 30:24 | 37:19 | 0.33 | ||
| Interval post-CVA (mos) | 44.7 ± 97.5 | 11 (6, 49) | 44.9 ± 79.2 | 18.5 (8, 45.5) | 0.27 |
| Etiology | 0.70 | ||||
| Embolic | 13 | 12 | |||
| Thrombotic | 17 | 23 | |||
| Lacunar | 9 | 6 | |||
| Hemorrhagic | 15 | 15 | |||
| Hemisphere | .09 | ||||
| Right | 35 | 27 | |||
| Left | 19 | 29 | |||
| DF absent: DF present | 14:40 | 15:41 | 0.70 | ||
| Fugl-Meyer (T1) | 20.1 ± 5.9 | 20 (16, 25) | 20.3 ± 6.0 | 21 (17, 24) | 0.73 |
| mEFAP (T1) | 121.5 ± 86.6 | 92.6 (59.0, 138.3) | 118.4 ± 74.1 | 90.7 (66.1, 154.4) | 0.80 |
| SSQOL (T1) | 179.1 ± 35.7 | 180.5 (150.5, 205.5) | 175.3 ± 40.7 | 180.0 (146, 210) | 0.81 |